Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.10
-0.40 (-1.31%)
Oct 30, 2026, 1:30 PM CST

Nang Kuang Pharmaceutical Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,1092,1622,2002,1501,9401,780
Revenue Growth
-7.50%-1.71%2.31%10.81%9.01%1.44%
Gross Profit
734.2768.86747.79755.56694.9594.47
Operating Income
261.23295.67310.22259.84321.67254.48
Net Income
205.39244.41243.41198.41352196.11
Earnings Per Share
2.032.412.401.963.481.94
EPS Growth
-23.07%0.42%22.45%-43.68%79.38%7.18%

Revenue by Geography

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Countries
10.9667.664.3154.4534.8226.62
Taiwan
1,7071,7031,6121,4211,3061,173
Mainland China
-209.24239.74407.41184.15362.6
Japan
-101.06190.08207.07240.9395.64
United States
-81.4593.2460.37174.14122.59
Total
2,1092,1622,2002,1501,9401,780

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
363.56345.67301.54378.48402.51418.41
Total Debt
684.35655.69638.23705.56409.13532.81
Net Cash (Debt)
-320.8-310.02-336.69-327.08-6.62-114.4
Net Cash Growth
------
Net Cash Per Share
-3.17-3.06-3.33-3.23-0.07-1.13

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
351.2464.08466.43342.61369.19556.63
Capital Expenditures
-206.54-277.82-524.6-297.51-93.84-156.05
Free Cash Flow
144.66186.25-58.1745.1275.35400.58
Free Cash Flow Growth
58.82%---83.62%-31.26%558.08%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
34.81%35.56%33.99%35.14%35.81%33.40%
Operating Margin
12.38%13.67%14.10%12.08%16.58%14.30%
Pretax Margin
11.52%13.47%13.78%9.94%21.16%13.19%
Profit Margin
9.74%11.30%11.06%9.23%18.14%11.02%
FCF Margin
6.86%8.61%-2.64%2.10%14.19%22.50%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.600-1.6002.0002.3001.800
Dividend Per Share Growth
0%--20.00%-13.04%27.78%12.50%
Dividend Yield
5.32%-3.89%3.75%3.60%4.67%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
14.8215.4117.0727.1318.3319.83
Forward PE
-14.9217.9519.6821.3014.55
P/FCF Ratio
21.0120.22-119.3623.449.71
PS Ratio
1.441.741.892.503.332.18